Related references
Note: Only part of the references are listed.Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium
Julia Riegger et al.
EUROPEAN HEART JOURNAL (2016)
Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion
Katsuya Miura et al.
AMERICAN HEART JOURNAL (2016)
Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography
Masanori Taniwaki et al.
CIRCULATION (2016)
Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry
Geraud Souteyrand et al.
EUROPEAN HEART JOURNAL (2016)
Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up
Shimpei Nakatani et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Influence of Sex on Long-Term Outcomes After Implantation of Bare-Metal Stent A Multicenter Report From the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1
Kyohei Yamaji et al.
CIRCULATION (2015)
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
Fumiyuki Otsuka et al.
EUROPEAN HEART JOURNAL (2015)
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study
Masanori Taniwaki et al.
EUROPEAN HEART JOURNAL (2015)
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus-and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)
Pieter C. Smits et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial
Marije M. Lowik et al.
EUROINTERVENTION (2015)
Ten-year clinical follow-up after sirolimus-eluting stent implantation
Nuno Palhais et al.
AMERICAN HEART JOURNAL (2014)
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents
Masanori Taniwaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents A Prospective Cohort Study
Lorenz Raeber et al.
CIRCULATION (2012)
Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Giulio Guagliumi et al.
CIRCULATION (2011)
Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial
Lorenz Raeber et al.
CIRCULATION (2011)
Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents Final 5-Year Analysis From the TAXUS Clinical Trial Program
Gregg W. Stone et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
The Pathology of Neoatherosclerosis in Human Coronary Implants Bare-Metal and Drug-Eluting Stents
Gaku Nakazawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
Gaku Nakazawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
Giulio G. Stefanini et al.
LANCET (2011)
Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer
Robert A. Byrne et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial
Giora Weisz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys et al.
LANCET (2009)
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston et al.
LANCET (2008)
Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents
Brendan Doyle et al.
CIRCULATION (2007)
Long-term clinical outcomes with sirolimus-eluting coronary stents - Five-year results of the RAVEL trial
Marie-Claude Morice et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
S Windecker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
